Health Care & Life Sciences » Biotechnology | Taxus Cardium Pharmaceuticals Group Inc.

Taxus Cardium Pharmaceuticals Group Inc. | Ownership

Companies that own Taxus Cardium Pharmaceuticals Group Inc.

Name
Shares Held
% Shares Out
Change In Shares
% of Assets
As of Date
Sabby Capital LLC
1,435,917
9.99%
64,935
0.06%
12/31/2017
Invesco Capital Management LLC
2,864
0.02%
0
0%
09/05/2018

About Taxus Cardium Pharmaceuticals Group

View Profile
Address
11750 Sorrento Valley Road
San Diego California 92121
United States
Employees -
Website http://www.cardiumthx.com
Updated 07/08/2019
Taxus Cardium Pharmaceuticals Group, Inc. is regenerative therapeutics company . The company focuses on the late-stage clinical and development of regenerative medicine therapeutics. Its product candidates include Generx, an interventional cardiology, angiogenic gene therapy product candidate designed for the treatment of cardiac microvascular insufficiency due to increasing coronary artery disease; and Excellagen, an acellular biological skin substitute designed as a wound care product for the treatment of chronic non-healing diabetic foot, venous and pressure ulcers.